The modification of serum lipids after acute coronary syndrome and importance in clinical practice

Current Cardiology Reviews

Volumn 7, Issue 4, 2011, Pages 272-276

  Balci, Bahattin ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Acute phase response; Lipid and lipoproteins

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALPHA FETOPROTEIN; APOLIPOPROTEIN B100; BLOOD CLOTTING FACTOR 12; C REACTIVE PROTEIN; CERULOPLASMIN; CHOLESTEROL; CHOLESTEROL ESTER; COMPLEMENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; FETUIN A; FIBRIC ACID DERIVATIVE; FIBRINOGEN; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; LIPID; LIPID BINDING PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ACUTE PHASE RESPONSE; ARTERY ENDOTHELIUM; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOCYTOSIS; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRIX; HEART MUSCLE INJURY; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LEUKOCYTOSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID OXIDATION; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; NEUROENDOCRINE DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ACUTE-PHASE REACTION; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS;

EID: 84861319096     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340311799960690     Document Type: Review

References (32)

1. Dodds C, Mills GL. Influence of myocardial infarction on plasma lipoprotein concentration. Lancet 1959; i: 1160-63
2. Scandinavian Simvastatin Survival Study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 2383-9
3. Ferrieres J, Cambou J-P, Cueret P, et al. Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry). Am. J. Cardiol 2005; 95: 486-9
4. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
5. Feingold K.R, Grunfeld C. The acute phase response inhibits reverse cholesterol transport. J Lipid Res 2010; 51: 682-4.
6. Prassl R, Laggner P. Molecular structure of low density lipoprotein: current status and future challenges. Eur Biophys J, 2009; 38: 145-158.
7. Stahelin RV. Lipid binding domains: more than simple lipid effectors. J Lipid Res 2009; 50: S299-S304.
8. Tsompanidi EM, Brinkmeier MS, Fotsadou EH, et al. HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis. Atherosclerosis 2010; 208: 3-9.
9. Jahangiri A, de Beer M.C, Noffsinger V, et al. HDL remodeling during the acute phase response. Arterscler Thromb Vasc Biol 2009; 29: 261-67.
10. Paoletti R, Gotto A.M, Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004; 109(suppl. III): 20-26.
11. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory Biomarkers in Acute Coronary Syndromes Part III: Biomarkers of Oxidative Stress and Angiogenic Growth Factors. Circulation 2006; 113: e289-292.
12. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
13. Packard R.R.S, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2008; 54: 24-38.
14. Biörck G, Blomquist G, Sievers J. Cholesterol values in patients with myocardial infarction and in a normal control group. Acta Med Scand 1957; 156: 493-7.
15. Pitt B, Loscalzo J, Ycas J, Raichlen J.S. lipid levels after acute coronary syndromes. J Am Coll Cardiol 2008; 51: 1440-45.
16. Rosenson R.S. Myocardial injury: The acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993; 22: 933-40.
17. Atalay s, Singer R, Kayadibi H, et al. Analytical performances of sentinel and vitros direct LDL-C assay methods and classification of patients with hyperlipidemia. Kafkas J Med Sci 2011; 1: 47-52.
18. Miller M. Lipid levels in the post-acute coronary syndrome setting. Destabilizing another myth? JACC 2008; 51: 1446-7.
19. Kwon SW, Yoon S-J, Kang TS, et al. Significance of small-dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J 2006; 47: 405-414.
20. Pfohl, M., Schreiber, I, Liebich, H.M., Hairing, H.U. and Haffmeister, H.M. (1999) Upregulation of cholesterol synthesis after acute myocardialinfarction-is cholesterol a positive acute phase reactant? Atherosclerosis 142, 389-393.
21. Gardner C.D, Fortmann S.P, Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875-81.
22. Barbagallo CM, Rizzo M, Cefalu AB, et al. Changes in plasma lipids and low-density lipoprotein peak particle size during and after myocardial infarction. Am J Cardiol 2002; 89: 460-2.
23. Miwa K, Memon R.A, Staprans I, et al. Low density lipoprotein particles are small in Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 2000; 20: 1536-42.
24. Van lenten B.J, Hama S.Y, De Beer F.C, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. J. Clin. Invest. 1995; 96: 2758-67.
25. Ansell B.J, Watson K.E, Fogelman A.E, et al. High-density lipoprotein function: Recent advences. JACC 2005; 46: 1792-8
26. Navab M, Amantharamaiah G.M, Reddy S.T, et al. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes 2009, 58: 2711-17.
27. McCann BS, Magee MS, Broyles FC, et al. Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: effects on plasma lipid and apoprotein concentrations. Psychosom Med 1995; 57: 165-176.
28. Mulder M, Lombardi P, Jansen H, et al. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase, J. Biol. Chem. 1993; 268: 9369-75.
29. Harvengt C, Heller FR, Martiat P, et al. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects. J Clin Pharmacol 1987; 27: 475-480.
30. Yanagibori R, Kondo K, Suzuki Y, et al. Effect of 20 days bed rest on the reverse cholesterol transport system in healthy young subjects. J Intern Med. 1998; 243: 307-12.
31. Nigam P.K, Narain V.S, Hasan M. Serum lipid profile in patients with acute myocardial infarction. Indian J Clin Biochem 2004; 19: 67-70.
32. Heinecke J.W. The HDL proteome: a marker and perhaps mediatorof coronary artery disease. J. Lipid Res.2009; 50(suppl.): 167-71.